National Health Data Registers: A Nordic heritage to public health

Scandinavian Journal of Public Health

Volumn 30, Issue 2, 2002, Pages 81-85

  Rosén, Måns ^a  

^a Epidemiologiskt Centrum   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN K GROUP;

CANCER REGISTRY; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CAUSE OF DEATH; CHILDHOOD CANCER; CIGARETTE SMOKING; CONGENITAL MALFORMATION; DATA ANALYSIS; EDITORIAL; HEALTH HAZARD; HEALTH SERVICE; HEART INFARCTION; HOSPITAL DISCHARGE; HUMAN; INFORMED CONSENT; LAW; LUNG CANCER; PRIORITY JOURNAL; PUBLIC HEALTH; RADIATION EXPOSURE; REGISTER; RISK FACTOR; HEALTH SERVICES RESEARCH; MANAGEMENT; NOTE; SCANDINAVIA;

HEALTH SERVICES RESEARCH; HUMANS; PATIENT IDENTIFICATION SYSTEMS; PUBLIC HEALTH; REGISTRIES; SCANDINAVIA;

EID: 0036370178     PISSN: 14034948     EISSN: None     Source Type: Journal    
DOI: 10.1177/14034948020300020101     Document Type: Editorial

References (37)

1. Pershagen G., Åkerblom G., Axelsson O., Clavensjö B., Damber L., Lagarde F., et al. Residential radon exposure and lung cancer in Sweden. N Engl J Med 1994; 33: 159-164.
2. Feychting M., Ahlbom A. Magnetic fields and cancer in children residing near Swedish high voltage power lines. Am J Epidemiol 1993; 138: 467-481.
3. Adami H.O., Sparén P., Bergström R., Holmberg L., Krusemo U.B., Pontén J. Increasing survival trend after cancer diagnosis in Sweden: 1960-1984. J Natl Cancer Inst 1989; 81: 1640-7.
4. Stenbeck M., Rosén M., editors. Cancer survival in Sweden in 1961-1991. Acta Oncol 1995; suppl. 4.
5. Adami H.O., Pontén J., Sparén P., Bergström R., Gustafsson L., Friberg L.G. Survival trend after invasive cervical cancer diagnosis in Sweden before and after cytologic screening, 1960-1984. Cancer 1994; 73: 140-7.
6. Bergström R., Sparén P., Adami H.O. Trends in cancer of the cervix uteri in Sweden following cytological screening. Br J Cancer 1999; 81: 159-166.
7. Ericson A., Gunnarskog J., Källén B., Otterblad Olausson P. Surveillance of smoking during pregnancy in Sweden, 1983-1987. Acta Obstet Gynaecol Scand 1991; 70: 111-117.
8. Norström M.-L., Cnattingius S. Smoking habits and birthweight in two successive birth cohorts in Sweden. Early Hum Dev 1994; 37: 195-204.
9. Cnattingius S., Haglund B. Decreasing smoking prevalence during pregnancy in Sweden: the effect for smallfor-gestational-age birth. Am J Public Health 1997; 87: 410-413.
10. Ericson A., Källén B. Pregnancy outcome in Sweden after the Chernobyl Accident. Environ Res 1994; 67: 149-159.
11. Ekelund H., Finnström O., Gunnarskog J., Källén B., Larsson Y.: Administration of vitamin K to newborn infants and childhood cancer. Br Med J 1993; 307: 89-91.
12. Otterblad Olausson P, Cnattingius S., Haglund B. Teenage pregnancies and risk of late fetal death and infant mortality. Br J Obstet Gynaecol 1999; 106: 116-121.
13. Bergh T., Ericson A., Hillensjö T., Nygren K.-G., Wennerholm. Deliveries and children born after in- vitro fertilization in Sweden 1982-1995: a retrospective cohort study. Lancet 1999; 354: 1579-1585.
14. Källén B. The teratogenicity of antireheumatic drugs- what is the evidence? Scand J Rheumatol 1998; 27(suppl. 107): 119-124.
15. Ericson A., Källén B., Wiholm B.-E. Delivery outcome after the use of antidepressants in early pregnancy. Eur J Clin Pharmacol 1999; 55: 503-8.
16. Golding J., Greenwood R., Birmingham K., Mott M. Childhood cancer, intramuscular vitamin K, and pethidine given during labour. Br Med J 1992; 305: 341-6.
17. Health in Sweden. The National Public Health Report 2001. Scand J Public Health 2001; suppl. 58: 1-239.
18. Hallqvist J., Lundberg M., Diderichsen F., Ahlbom A. Socioeconomic differences in risk of myocardial infarction 1971-1994 in Sweden: time trends, relative risks and population attributable risks. Int J Epidemiol 1998; 27: 410-415.
19. Alfredsson L., Spetz C.-L., Theorell T. Type of occupation and near-future hospitalization for myocardial infarction and some other diagnoses. Int J Epidemiol 1985; 14: 378-388.
20. Pollán M., Gustavsson P. Cancer and occupation in Sweden 1971-89. EpC Report 1999: 1.
21. Magnusson C., Baron J.A., Correia N., Bergström R., Adami H.O., Persson I. Breast-cancer risk following long-term oestrogen-and oestrogen-progestin replacement therapy. Int J Cancer 1999; 81: 339-344.
22. Naessén T., Persson I., Adami H.O., Bergström R., Bergkvit L. Hormone replacement therapy and the risk for first hip fracture: a prospective population-based cohort study. Ann Intern Med 1990; 113: 95-103.
23. Falkeborn M., Persson I., Terent A., Adami H.O., Lithell H., Bergström R. Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden. Arch Intern Med 1993; 153: 1201-9.
24. Falkeborn M., Persson I., Adami H.O., Bergström R., Eaker E., Lithell H., et al. The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynaecol 1992; 99: 821-8.
25. Tibblin G., Wilhelmsen L., Werkö L. Risk factors for myocardial infarction and death due to ischaemic disease and other causes. Am J Cardiol 1975; 35: 514-522.
26. Wilhelmsen L., Rosengren A., Eriksson H., Lappas G. Heart failure in the general population of men - morbidity, risk factors and prognosis. J Intern Med 2001; 249: 253-261.
27. Rosén M., Spetz C.-L., Hammar N. Coronary artery disease in men and women. N Engl J Med 1999; 341: 1931-2.
28. Rosengren A., Spetz C.-L., Köster M., Hammar N., Alfredsson L., Rosén M. Sex differences in survival after myocardial infarction in Sweden. Eur Heart J 2001; 22: 314-322.
29. Ringbäck Weitoft G., Gullberg A., Rosén M. Avoidable mortality among psychiatric patients. Soc Psychiatry Psychiatr Epidemiol 1998; 33: 430-7.
30. Ringbäck Weitoft G., Haglund B., Rosén M. Mortality among lone mothers in Sweden: a population study. Lancet 2000; 355: 1215-1219.
31. Rosén M., Alfredsson L., Hammar N., et al. Attack rate, mortality and case fatality for acute myocardial infarction in Sweden 1987-1995. Results from the Swedish Myocardial Infarction Register. J Internal Med 2000; 248: 159-164.
32. Nyström L., Larsson L.-G., Rutqvist L.E., Lindgren A., et al. Determination of cause of death among breast cancer cases in the Swedish randomized mammography screening trials. A comparison between official statistics and validation by an endpoint committee. Acta Oncologica 1995; 34: 145-152.
33. Allebeck P. The revised Helsinki declaration: Good for patients? Good for public health? Scand J Public Health 2002; 30: 1-4.
34. Andersson H., Möller T.R. Familial breast and ovarian cancer: a Swedish population-based study. Am J Epidemiol 2000; 152: 1154-1163.
35. Lambe M., Hsieh C.-C., Chan H.-W., Ekbom A., Trichopoulos D., Adami H.O. Parity, age at first and last birth and risk of breast cancer. A population based study in Sweden. Breast Cancer Res Treat 1996; 38: 305-311.
36. Nyström L., Rutqvist L.E., Wall S., et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 1993; 341: 973-8.
37. Blomqvist P., Andersson R.E., Granath F., Lambe M.P., Ekbom A. Mortality after appendectomy in Sweden 1987-1996. Ann Surgery 2001; 233: 455-460.